Physician profile

Heather L Bellanger

Obstetrics & Gynecology · Plano, TX

NPI 1851594840

$3,707.24

in general payments reported to CMS, 2019-2025

43 companies · $615 in 2025

The $615 reported for 2025 was more than what 84% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).

See the full distribution for Obstetrics & Gynecology

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$1,869.73
Education$72.99

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Organon LLC $429.84 2021-2025 Nexplanon
Pfizer INC. $295.60 2019-2025
Sumitomo Pharma America, INC. $261.76 2023-2025 Myfembree
Allergan, INC. $253.90 2020-2021
Astellas Pharma US INC $237.47 2019-2025 Veozah, Myrbetriq
Abbvie INC. $222.67 2019-2023 Lo Loestrin Fe, Orilissa
Kvk-Tech, INC. $205.32 2019-2021
Exeltis, USA INC. $160.75 2021-2025 Slynd
Applied Medical Resources Corporation $160.00 2021
Integra Lifesciences Corporation $153.50 2023 Medihoney, Biodrestore, Biodfactor
Hologic Sales and Service, LLC $151.02 2019-2023 Coolseal Generator, Novasure, Acessa Provu System
Sage Therapeutics, LLC $113.66 2024-2025 Zurzuvae
Millicent US INC $85.79 2019-2025 Femlyv, Femring, Intrarosa
Smith+Nephew, INC. $69.13 2019
Bayer Healthcare Pharmaceuticals INC. $68.50 2019-2023
Show all 43 companies
CompanyGeneral paymentsYearsTop products
Myovant Sciences INC. $68.12 2021-2022
Therapeuticsmd, INC. $68.02 2019-2021
Mayne Pharma Commercial LLC $62.21 2022-2023
Lupin INC. $56.11 2019-2020
Idorsia Pharmaceuticals US INC $50.00 2022-2024 Quviviq
Innovation Technologies INC $48.21 2023 Irrisept
Daiichi Sankyo INC. $43.00 2019-2024 Injectafer
Avion Pharmaceuticals $40.32 2019-2021
Nalpropion Pharmaceuticals LLC $37.20 2019
Axonics, INC. $33.80 2024 Axonics
Duchesnay USA Incorporated $29.60 2019
Mission Pharmacal Company $28.74 2019-2020
Novo Nordisk INC $28.09 2019-2020
Minerva Surgical, INC $26.04 2021-2023
Medtronic, INC. $23.67 2022
Vertex Pharmaceuticals Incorporated $23.51 2025
Intuitive Surgical, INC. $22.49 2023 Da Vinci Surgical System
Merck Sharp & Dohme LLC $21.83 2019
Amgen INC. $21.30 2025 Evenity, Prolia
Baxter Healthcare $19.72 2021
Salix Pharmaceuticals, A Division of Bausch Health US, LLC $18.28 2019
Supernus Pharmaceuticals, INC. $15.72 2025 Qelbree
Coloplast Corp $12.89 2019
Amag Pharmaceuticals, INC. $11.94 2019
Medicem INC. $11.62 2021
Currax Pharmaceuticals LLC $10.56 2019
Bolder Surgical LLC $4.08 2019
Meditrina $1.26 2022

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Heather L Bellanger

$3,707.24

in general payments reported 2019-2025

Years
2019-2025
Top company
Organon LLC
Context
The $615 reported for 2025 was more than what 84% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).

https://glasscript.com/doctor/220866/heather-l-bellanger

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.